Keene & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $2.91M | Buy |
29,240
+2,485
| +9% | +$247K | 2.34% | 23 |
|
2024
Q3 | $3.04M | Buy |
26,755
+570
| +2% | +$64.7K | 2.3% | 25 |
|
2024
Q2 | $3.24M | Sell |
26,185
-7,205
| -22% | -$892K | 2.64% | 21 |
|
2024
Q1 | $4.41M | Sell |
33,390
-999
| -3% | -$132K | 3.29% | 2 |
|
2023
Q4 | $3.75M | Sell |
34,389
-358
| -1% | -$39K | 3.11% | 5 |
|
2023
Q3 | $3.58M | Buy |
34,747
+382
| +1% | +$39.3K | 2.87% | 8 |
|
2023
Q2 | $3.97M | Sell |
34,365
-55
| -0.2% | -$6.35K | 3.08% | 5 |
|
2023
Q1 | $3.66M | Sell |
34,420
-2,148
| -6% | -$229K | 2.84% | 9 |
|
2022
Q4 | $4.06M | Sell |
36,568
-5,017
| -12% | -$557K | 3.62% | 4 |
|
2022
Q3 | $3.58M | Sell |
41,585
-535
| -1% | -$46.1K | 3.29% | 3 |
|
2022
Q2 | $3.84M | Sell |
42,120
-160
| -0.4% | -$14.6K | 3.59% | 1 |
|
2022
Q1 | $3.47M | Buy |
42,280
+3,838
| +10% | +$315K | 2.83% | 8 |
|
2021
Q4 | $2.95M | Buy |
+38,442
| New | +$2.95M | 2.55% | 19 |
|